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Consequences of subacute
intratracheal exposure of rats to
cadmium oxide nanoparticles:
Electrophysiological and toxicological
effects
Andra´s Papp1, Ga´bor Oszla´nczi1, Edina Horva´th1,
Edit Paulik1, Ga´bor Kozma2, Andra´s Sa´pi2,
Zolta´n Ko´nya2 and Andrea Szabo´1
Abstract
Cadmium (Cd) is a metal used in various industrial applications, thereby causing exposure to Cd-containing
fumes. The submicron-sized particles in the fumes represent an extra risk due to their high mobility within the
organism and high surface area. Toxicity of Cd on the liver, kidney and bones is well known, but there are less
data on its neurotoxicity. Here, male Wistar rats were treated for 3 and 6 weeks by intratracheal instillation of
cadmium oxide nanosuspension. The body weight gain in treated rats was significantly decreased, and in the
rats treated with high dose (0.4 mg/kg Cd daily), there was a significant increase in the weight of lungs and thy-
mus. In this group, the spectrum of spontaneous cortical electrical activity was shifted to higher frequencies,
the latency of sensory-evoked potentials was lengthened, and the frequency following ability of the somatosen-
sory evoked potential was impaired—even without detectable Cd deposition in the brain. The data support the
role of the nano-sized Cd in the causation of nervous system damage and show the possibility of modeling
human neurotoxic damage in rats.
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Introduction
Environmental conditions constitute one of the four
major determinants of human health, and the medium
causing the most direct exposure to harmful substances
is air. Airborne particulate matter can be classified as
sedimenting dust (>10 mm), suspended or fine dust
(100 nm–10 mm; often called PM10) and ultrafine dust
or nanoparticles (NPs, <100 nm).
NPs as pollutants arise mainly from combustion
and other high-temperature processes (smelting, cast-
ing, welding of metals, etc.) (Antonini et al., 2003).
Another potential source of exposure to NPs today
is nanotechnology. Manufactured nanomaterials are
present in numerous consumers’ goods and in techni-
cal applications ( Oberdo¨rster et al., 2005 ). Quantum
dots, novel nanotechnological materials (with appli-
cation, among others, in biomedical research) often
contain cadmium (more precisely, cadmium telluride)
and show special toxicological properties (Rziga-
linski and Strobl, 2009). Cd-containing metal dust and
fumes, or paint spray, cause occupational airborne
exposure in manufacturing and application of e.g.
steel and other alloys, pigments and semiconductor
materials (ATSDR, 2008).
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Inhaled NPs are either deposited in the
nasopharynx or get down to the alveoli (ICRP,
1994). Once deposited, NPs translocate readily to
other body parts and reach target organs by different
transfer routes and mechanisms, including transcyto-
sis (by caveola formation) across epithelia of the
respiratory tract into the interstitium (Oberdo¨rster et
al., 2005) and axonal transport along the olfactory
fibers directly into the central nervous system (CNS)
(Calderon-Garciduenas et al., 2002). Due to their
small size, number concentration and large specific
surface area, NPs have greater biological activity per
given mass than larger particles (Oberdo¨rster et al.,
2005), including oxidative stress induction (Li et al.,
2003). In the target organs, the components of the NPs
also exert their own toxic effects, after transport to
these sites in whole or after being dissolved from the
surface of the NPs (Lundborg et al., 1985). Cadmium,
in airborne forms, is absorbed from the respiratory
tract in 2–50%, depending primarily on particle size
(Chaney et al., 2004). Its several target organs include
the lungs, liver, kidney, testis, placenta, as well as the
nervous system (ATSDR, 2008). Concerning the lat-
ter, the reported consequences of chronic Cd exposure
include amyotrophic lateral sclerosis, optic nerve
damage, striatal damage and peripheral polyneuropa-
thy (Bar-Sela et al., 2001; Fern et al., 1996; O’Calla-
ghan and Miller, 1986; Viaene et al., 1999). In
children, a straight relationship between hair Cd and
altered visual- or auditory (AUD)-evoked potential
(EP) parameters was found (Thatcher et al., 1984),
and school behavioral problems were also reported
(Marlowe et al., 1985). Similar effects were observed
in rats (Agar et al., 1999). In our previous works, oral
application of Cd to rats for several weeks resulted in
altered electrocorticogram (ECoG) power spectrum
and in changes of cortical EPs and peripheral nerve
action potentials (Instito´ris et al., 2002; Papp et al.,
2003). In the present work, a potentially more realistic
way of exposure—intratracheal application of cad-
mium oxide (CdO2) NPs—was chosen, and the gen-
eral toxicological and electrophysiological
measurements were supplemented with some bio-
chemical ones.
Materials and methods
Animals and treatment
Adult male Wistar rats of 320–350 g body weight
(b.w.) were obtained from the breeding center of the
university and were housed under standard conditions
(22–24C, 12-h light/dark cycle with light on at
06:00) with free access to tap water and standard
pellet. The rats were divided into 4 groups of 20 ani-
mals each at start.
Cadmium dioxide NPs were synthesized at the
Department of Applied Chemistry by a dry process.
Stoichiometric amount of CdCl2 and Na2CO3 were
put, in NaCl matrix, in the drum of a planetary ball
mill and rotated with stainless steel mill balls at
400 rpm for 4 h (reaction 1: CdCl2 þ Na2CO3
! CdCO3 þ 2 NaCl). The mixture milled this way
was then calcined at 480C for 4 h in air (reaction
2: CdCO3þ½O2! CdO2þ CO2). After calcination,
the synthesis mixture was filtered (0.45 mm polytetra-
fluoroethylene membrane filter) and washed with
80C preheated water to remove any unreacted start-
ing material and the soluble NaCl matrix. The preci-
pitate was dried at 100C for 1 h and characterized
with X-ray diffraction and transmission electron
microscopy. The size distribution and electron micro-
graph of the CdO2 NPs is shown in Figure 1.
The synthesized NPs were suspended in distilled
water and were instilled into the rats’ trachea, in daily
doses shown in Table 1, 5 days a week (Monday to
Friday). The volume instilled was 1 ml/kg b.w. Treat-
ment was continued for 3 and 6 weeks, whereby 10
rats from each group were killed after 3 weeks of
treatment and the remaining 10 after 6 weeks. There
was an untreated control group (Con), and a vehicle
control group (W). The choice of doses was influ-
enced by literature data and by the technically possi-
ble concentration of the NPs in the distilled water
medium. Calculating with ca. 0.5 m3/kg b.w. the daily
breathing volume for the rats (based on data by Strohl
et al., 1997), our lower dose is comparable to that
reported from industrial settings (ca. 30 mg/m3,
indoors in car body repair shops: Vitayavirasuk et
al., 2005; or 1–19 mg/m3, outdoors in bridge mainte-
nance: Conroy et al., 1995), and the higher one, to the
550 mg/m3 used by Takenaka et al. (2004) in a rat
inhalation experiment. A more direct comparison is,
however, impossible because of the unknown reten-
tion fractions.
Intratracheal instillation was done in diethyl ether
anesthesia, with the rat suspended on a 60 inclined
board so that its upper incisors were held by a wire
loop to keep the animal’s mouth open. The trachea
was illuminated transdermally. The tongue was pulled
forward with a pair of nontraumatic forceps, and a
custom-made laryngoscope was used to visualize the
glottis. The nanosuspension (or distilled water for
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group W) was instilled into the trachea by means of a
syringe and 1.2 mm outer diameter plastic tubing,
inserted between the vocal chords. The group Con had
neither ether anesthesia nor instillation, while the
water control (W) group was anesthetized and
instilled with distilled water. The nanosuspension was
vigorously sonicated before, and repeatedly during,
administration to prevent agglomeration.
General toxicological and biochemical
measurements
Body and organ weights were the end points for
general toxic effect of the CdO2 NPs. The rats’ b.w.
was measured each workday during the treatment
period, and the mean b.w. of the groups was plotted
against time to see the course of weight gain. Follow-
ing electrophysiology (see below), the rats were killed
by an overdose of urethane, dissected, and the organ
weight of the brain, liver, lungs, heart, kidneys,
spleen, thymus and adrenals was measured. Relative
weights were calculated by relating organ weights to
brain weight. To reduce costs, 5 of the 10 rats from
each group were randomly assigned for chemical
measurements. Of these, blood, brain, lung and liver
samples were taken and stored at 22C.
Metal level was determined from ca. 1 g of the
samples, dried at 80C to constant weight and
digested in 5 ml of 65% HNO3 at 90
C for 90 min.
After filtration and dilution, metal level was deter-
mined by inductively coupled plasma mass spectro-
metry (at the laboratory of the MOL Hungarian Oil
and Gas Company).
For biochemical measurements, another 1 g of
the samples was homogenized with 4 ml saline and
centrifuged under cooling for 10 min at 5000 rpm.
The supernatant was centrifuged again for 20 min
at 14,000 rpm.
From the supernatant, protein content was mea-
sured according to Lowry et al. (1951). As oxidative
stress indicators, reduced glutathione (GSH) mea-
sured by the method of Sedlak and Lindsay (1968),
Figure 1. Size distribution histogram (a) and electron micrograph (b) of the CdO2 nanoparticles. Scale bar: 100 nm.
Table 1. Treatment groups and doses
Group Code Treatment and dose Duration
Untreated control Con – 3 and 6 weeksa
Vehicle control W Distilled water 1 ml/kg b.w.
Low dose LD CdO2 nanosuspension, 0.04 mg Cd/kg b.w.; 1 ml/kg b.w.
High dose HD CdO2 nanosuspension, 0.4 mg Mn/kg b.w.; 1 ml/kg b.w.
aThere were 20 rats in each group at start. Ten of them were processed and killed after 3 weeks of treatment, and the another 10, after
6 weeks of treatment.
Papp et al. 935
 by guest on October 25, 2012tih.sagepub.comDownloaded from 
based on the reaction of nonprotein-bound SH groups
with the Ellman reagent (5, 50-dithio-bis(2-nitroben-
zoic acid)), was used. Another oxidative stress
parameter, superoxide dismutase (SOD) activity, was
measured by the method of Misra and Fridovich
(1972), modified by Matkovics et al. (1982), based
on inhibition of the spontaneous adrenaline-adreno-
chrome transformation.
Electrophysiological measurements
Electrophysiological recording was done 1–3 days
after the last instillation. In urethane anesthesia, the
animal’s head was fixed and the sensory areas of left
hemisphere were exposed. The wounds were sprayed
with 10% lidocaine, and a thin layer of petroleum
jelly was applied on the dura to prevent drying. After
30 min recovery, silver electrodes were placed on the
primary somatosensory (SS), visual (VIS) and AUD
areas. ECoG was recorded from these areas for 6 min,
and the relative spectral power of the frequency bands
(delta, theta, alpha, beta1, beta2, gamma; standard
human EEG bands) was determined. Then, sensory
EPs were recorded by the same electrodes. For SS sti-
mulation, two needles were inserted into the contral-
ateral whiskery skin to deliver square electric pulses
(3–4 V, 0.05 ms, 1–10 Hz). VIS stimulation was pro-
duced by a high-luminance white light-emitting diode
aimed directly at the rat’s right eye, driven by 0.2 ms
pulses at 1 Hz. The AUD stimuli were clicks (1 Hz,
40 dB) guided from a miniature earphone into the ani-
mal’s right ear via the hollow ear bar. Fifty stimuli of
each modality per rat were applied and the EPs
recorded. After averaging, latency and duration of the
EPs was measured manually (for details, see Luka´cs
and Szabo´, 2007). The change in latency of the SS
EP with increasing stimulation frequency was also
investigated as a possible indicator of the action of the
treatment on the state of the cortex. All electrophysio-
logical recording and analysis was done by means of
the Neurosys 1.11 software (Experimetria Ltd, Buda-
pest, Hungary). The study was approved by the Ethi-
cal Committee for the Protection of Animals in
Research of the University. During the whole proce-
dure, the principles of the Committee (based on the
EU-conform Hungarian law) were strictly followed.
Data processing
From the data, group means (+SD) were calculated.
The results were tested for significance with one-way
analysis of variance and the post hoc analysis was
done by Scheffe’s test.
Results
Body and organ weights
Intratracheal exposure by the nanoparticulate CdO2
had marked effect on the b.w. gain in rats. As shown
in Figure 2, the untreated controls’ (Con) weight
gain was undisturbed. In the vehicle control (W)
group (anesthesia and instillation but no CdO2 NPs),
the weight gain was lower, and with the advance of
time became more and more similar to that seen in
the treated rats. In the high-dose (HD) group, there
was hardly any weight increase in the first 2 weeks.
Figure 2. Body weight gain of the treated and control rats over the 6 weeks of treatment period. Always the data from
the first workday of the corresponding week are plotted. Mean þ SD, n ¼ 10. Insert: group codes, see Table 1 for expla-
nation. *p < 0.05, **p < 0.01, ***p < 0.001 vs. untreated control group (Con); ##p < 0.01, ###p < 0.001 vs. vehicle control
group (W).
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Then, some compensation seemed to take effect and
the weight gain was similar to that seen in the low-
dose (LD) group and approached that of the vehicle
control (W).
The relative weight of the lungs was significantly
higher in the HD group vs. Con after 6 weeks of
exposure (Table 2). In the W and LD groups, there
was no noteworthy increase. There was also signifi-
cant increase in the relative thymus weight in the HD
group, and decrease in the relative spleen and liver
weight in the treated groups. After only 3 weeks of
treatment (not shown), the trends were similar but
less expressed.
Brain weight itself was little influenced by the Cd
NP treatment (after 6 weeks of exposure: Con,
1.278 + 0.054 g; W, 1.156 + 0.91 g; Cd-LD,
1.169+ 0.091 g; Cd-HD, 1.189+ 0.134 g)—so the
relative organ weights were not biased.
Cadmium levels and oxidative stress indicators
A shown in Table 3, most of the Cd content of the
instilled NPs was located in the lungs but a significant
amount was absorbed and deposited in the liver in a
dose-dependent manner. In the brain (and blood),
however, no Cd was detected.
Table 2. Relative organ weights after 6 weeks of exposure to Cd nanoparticlesa
Groups organs Con W Pb-LD Pb-HD
Lungs 0.787 + 0.067 0.692 + 0.084 0.831 + 0.088 1.359+ 0.254b,c
Liver 7.323 + 0.718 7.198 + 1.071 6.549 + 0.502d 6.198+ 0.595
Kidney 1.407 + 0.070 1.350 + 0.089 1.311 + 0.172 1.379+ 0.146
Heart 0.583 + 0.031 0.542 + 0.043 0.558 + 0.039 0.556+ 0.066
Spleen 0.468 + 0.062 0.358 + 0.040 0.334 + 0.056b 0.387+ 0.041e
Thymus 0.213 + 0.026 0.194 + 0.033 0.207 + 0.017 0.277+ 0.056e,f
Adrenals 0.028 + 0.008 0.027 + 0.007 0.029 + 0.008 0.029+ 0.008
Con: untreated control group; HD: high-dose group; LD: low-dose group, W: vehicle control group.
aMean+ SD, n ¼ 10.
bp < 0.001 vs. Con.
cp < 0.001 vs. W.
dp < 0.05 vs. Con.
ep < 0.01 vs. Con.
fp < 0.01 vs. W.
Table 3. Cd deposition and reduced glutathione level in tissue samples of rats after 6 weeks of exposure by CdO2 NPs
a
Treatment groups
W Cd-LD Cd-HD
Cd level (mg/kg)
Brain 0 0 0
Liver 26+ 26 683+ 271b 9986+ 4171b,c
Lung 1707+ 1391 43,020 + 23,904d 268,399 + 199,844d,e
GSH (mM)
Brain 0.0895+ 0.0037 0.0914 + 0.0075 0.1071 + 0.0035f,g
Liver 0.0729+ 0.0040 0.0806 + 0.0065 0.1062 + 0.0020
Lung 0.2080+ 0.1780 0.2398 + 0.1335 0.1681 + 0.1620f,g
HD: high-dose group; LD: low-dose group, NPs: nanoparticles; W: vehicle control group.
aMean+ SD, n ¼ 5.
bp < 0.01 vs. W.
cp < 0.01 vs. Cd-LD.
dp < 0.05 vs. W.
ep < 0.05 vs. Cd-LD.
fp < 0.001 vs. W.
gp < 0.001 vs. Cd-LD.
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SOD activity was affected neither in the brain nor
in the lung and liver (in which organs Cd deposition
was detected). The level of GSH was, on the contrary,
dose-dependently influenced and the HD vs. W differ-
ence was significant in the lungs and the brain.
Electrophysiological effects
The alterations in the spontaneous cortical activity
(ECoG) were alike in all three cortical areas. There
was a dose- and time-dependent shift from slower to
faster waves which became significant in the HD
group after 6 weeks of exposure (Figure 3). After
3 weeks only, no significant changes were seen.
The SS EP showed significant increase in
latency in the HD group vs. Con at each stimula-
tion frequency (Figure 4). The slight dependence
of the latency on the frequency of stimulation, seen
in Con and W, was more expressed in the treated
groups, up to the significant difference between the
latencies obtained with 1 and 10 Hz stimulation in
the HD group. The latency of the VIS EP, and to a
lesser extent of the AUD EP, also increased in the
treated groups vs. Con (Figure 5).
Figure 3. Band power spectrum (delta to gamma, see insert) of the rats’ electrocorticogram after 6 weeks of exposure.
Abscissa: group codes. SS: somatosensory area; VIS: visual area; AUD: auditory area. *p < 0.05 vs. untreated control group
(Con); #p < 0.05 vs. vehicle control group (W).
Figure 4. Latency of the somatosensory-evoked potential after 6 weeks of exposure. Abscissa: group codes. Mean+ SD,
n¼ 10. Insert: stimulation frequency. *p < 0.05 vs. untreated control group (Con); p < 0.05 vs. 1 Hz stimulation within the
same treatment group.
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Discussion
The metal levels, as well as the electrophysiological
and biochemical changes, indicated that Cd instilled
into the rats’ trachea in the form of CdO2 NPs was in
fact absorbed from the airways and unfolded its toxi-
city. The time trend of body weights and the increase
in alterations after 6 vs. 3 weeks suggested a gradual
buildup of Cd. Absorption of the metal via the air-
ways has been described repeatedly. Takenaka et
al. (2004) detected Cd in the blood, liver and kidney
of rats after inhalation CdO2 NPs—in an experiment
with much shorter duration, and faster tissue sam-
pling after exposure than it was in our work, which
may explain the main difference viz. the absence
of detectable Cd level in the blood of treated rats.
In bulk, CdO2 is hardly water soluble, but its absorp-
tion from the lung is rather good (Oberdo¨rster,
1979). No detectable blood Cd level in our work
probably meant that the absorbed amount was
promptly sequestered in the liver where it was
detected in fact. In the study by Dill et al. (1994), the
blood Cd level after ca. 3 months inhalation expo-
sure by CdO particles of about 1 mm diameter was
103 times lower than in the kidney, the other organ
known to accumulate Cd in the organism. The
absence of noteworthy amounts of Cd in the blood
was, logically, the reason for not detecting Cd in our
brain samples. Beyond that, Cd is known to have low
permeability across the blood–brain barrier
(ATSDR, 2008) and no transneuronal movement
from the periphery to the brain (Tja¨lve et al., 1996).
In spite of the latter, neurotoxicity of Cd in humans
has been reported repeatedly (see Introduction sec-
tion). In exposed workers, elevated urine Cd level was
associated with reduced visuomotor performance and
difficulties of concentration and stance (Viaene et al.,
2000) and with peripheral neuropathy (Viaene et al.,
1999). In children, the exposure indicator was hair
Cd, and the outcomes, cortical EPs (Thatcher et al.,
1984) and behavior (Marlowe et al., 1985). The signif-
icant change in the latency of cortical EPs in our work,
without detectable Cd deposition in the CNS, was
probably due to secondary effects. Along the periph-
eral part of the afferent pathways, Cd2þ ions, if present,
could interfere with ion channels (primarily Ca chan-
nels: Viarengo and Nicotera, 1991), and with mito-
chondrial energy production (Lo´pez et al., 2006),
resulting in delayed arrival of the excitation to the sub-
cortical and cortical centers, and so to lengthened cor-
tical EP latency. Cd-induced liver damage could affect
the substrate supply for synthesis of monoamine trans-
mitters (Yourdaydin et al., 1990), the abnormal activ-
ity ofwhich is known to alter cortical electrical activity
(Sebban et al., 1999). The ECoG shift in the present
study was similar to that found with oral application
of dissolved Cd for 12 weeks (Papp et al., 2003).
The oxidative stress inducing effect of Cd is indi-
rect; due, among others, to depletion of GSH (Valko
et al., 2005) and to mitochondrial damage (Lo´pez et
al., 2006). The GSH level in the lungs of treated rats
(the organ having the highest Cd load) was in fact sig-
nificantly reduced. The increase in the brain samples
was possibly of compensatory nature. Others, e.g.
Figure 5. Latency of the visual- and auditory (see insert)-evoked potential after 6 weeks of exposure. Abscissa: group
codes. Mean+ SD, n ¼ 10. *p < 0.05, **p < 0.01 vs. untreated control group (Con).
Papp et al. 939
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Tandon et al. (2003), found depletion of GSH in Cd-
exposed rats but in that experiment Cd was applied
per os in dissolved form, in higher dose (1.5 mg/kg
b.w.) and was detected in brain samples after 5 days
treatment.
In spite of some disagreements with others’ find-
ings, it can be stated that the data, presented above,
emphasize the role of the nano-sized fraction of
Cd-containing industrial fumes in the causation of
nervous system damage, and show that it is possible
to model the human neurotoxic damage caused by
inhalational Cd exposure in rats.
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